Peripheral Artery Disease Market Developments Driving Growth

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Is The Market Size Of The Peripheral Artery Disease Market Expected To Change From 2026 To 2030?

The peripheral artery disease market size has shown substantial growth in recent years. It is projected to increase from $4.62 billion in 2025 to $4.97 billion in 2026, achieving a compound annual growth rate (CAGR) of 7.5%. This historical expansion can be linked to the high prevalence of peripheral artery disease, limited awareness of PAD risk factors, reliance on traditional medications, inadequate access to interventional specialists, and fragmented patient care pathways.

The peripheral artery disease market is projected to experience substantial expansion in the coming years. Its valuation is set to reach $6.69 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.8%. This projected growth is driven by several factors, including advancements in minimally invasive peripheral interventions, the increasing use of drug-eluting balloons and stents, the expansion of hospitals and specialized vascular clinics, heightened patient awareness and early detection efforts, and the rising application of combination therapies encompassing lifestyle adjustments and pharmacotherapy. Key trends anticipated during this period involve the increasing application of AI for early PAD diagnosis and risk stratification, a growing uptake of cloud-based patient monitoring systems, an amplified focus on genomic-guided personalized PAD treatments, greater integration of IoT devices for tracking post-intervention recovery, and the increasing implementation of smart manufacturing in the production of PAD devices.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12068&type=smp

Which Key Drivers Are Affecting The Peripheral Artery Disease Market Development?

An increasing incidence of peripheral artery diseases is projected to drive the expansion of the peripheral artery disease market in the future. Peripheral artery disease describes the constriction or obstruction of arteries located beyond the heart, typically in the legs, which leads to diminished blood circulation and possible health issues. Treatments for peripheral artery disease aid in alleviating its symptoms, improving patient mobility, and lowering the likelihood of serious complications, thereby enhancing overall patient well-being. For example, data from June 2023, provided by the American Heart Association, a US-based nonprofit organization, indicates that approximately 7 to 12 million individuals in the United States and 200 million people globally are living with this condition. Consequently, the growing prevalence of peripheral artery diseases is fueling the development of the peripheral artery disease market.

Which Segment Types Are Examined In The Peripheral Artery Disease Market Segment Study?

The peripheral artery disease market covered in this report is segmented –

1) By Type: Peripheral Angioplasty Balloons, Peripheral Stents, Peripheral Catheters, Inferior Vena Cava (IVC) Filters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Peripheral Accessories

2) By Drugs: Lipid-Lowering Drugs, Blood Pressure Lowering Drugs, Glucose Regulating Drugs, Blood Clot Preventing Drugs, Inotropes, Thrombolytics Agents, Anti-Inflammatory Agents

3) By Route Of Administration: Oral, Parenteral, Other Routes Of Administrations

4) By End Users: Hospitals, Specialty Clinics, Other End Users

Subsegments:

1) By Peripheral Angioplasty Balloons: Drug-Eluting Balloons, Non-Drug-Eluting Balloons, Scoring Balloons, Cutting Balloons

2) By Peripheral Stents: Drug-Eluting Stents, Bare Metal Stents, Covered Stents

3) By Peripheral Catheters: Sheath Introducers, Guidewires, Diagnostic Catheters, Delivery Catheters

4) By Inferior Vena Cava (IVC) Filters: Retrievable IVC Filters, Permanent IVC Filters

5) By Plaque Modification Devices: Atherectomy Devices, Laser Atherectomy Devices, Rotational Atherectomy Devices

6) By Hemodynamic Flow Alteration Devices: Flow Diversion Devices, Flow Restriction Devices

7) By Peripheral Accessories: Diagnostic Imaging Accessories, Accessory Kits For Interventional Procedures, Support Devices

What Trends Are Transforming The Peripheral Artery Disease Market?

Leading companies operating within the peripheral artery disease (PAD) market are concentrating on developing innovative solutions, such as dissolvable drug-eluting scaffold systems. This effort aims to meet the increasing demand for safer, more durable, and less invasive treatment options for arterial blockages located below the knee. These resorbable scaffold technologies are designed to restore blood flow and then gradually dissolve, offering a significant advantage over traditional permanent metallic stents. For instance, in April 2024, Abbott Laboratories, a U.S.-based medical-device company, launched the Esprit BTK Everolimus Eluting Resorbable Scaffold System, marking it as a first-of-its-kind dissolvable stent therapy for below-the-knee PAD. The system delivers everolimus, a drug that helps prevent vessel re-narrowing, while its fully resorbable structure naturally dissolves over time, thereby eliminating the long-term risks associated with metal implants. It offers physicians an advanced alternative to traditional angioplasty or permanent stenting, proving particularly beneficial for patients with long lesions or critical limb ischemia. By combining drug delivery with temporary structural support, the Esprit BTK System aims to enhance vessel healing, reduce complications, and expand treatment possibilities in complex PAD cases.

Which Players Are Part Of The Competitive Landscape Of The Peripheral Artery Disease Market?

Major companies operating in the peripheral artery disease market are Cardinal Health Inc., Vascular Solutions Inc., Bayer AG, Abbott Laboratories, Medtronic plc., Koninklijke Philips N.V. (Royal Philips), B. Braun Melsungen AG., Terumo Corporation, Edwards Lifesciences, Becton Dickinson and Company (BD), Boston Scientific Corporation Incorporated, Cook Group Incorporated, Merit Medical Systems Inc., NuVasive Inc., Arjo AB, Penumbra Inc., BIOTRONIK SE and Co. KG, AngioDynamics Inc., Shockwave Medical Inc., Cardiovascular Systems Inc., Endologix LLC., LeMaitre Vascular Inc., Silk Road Medical Inc., WL Gore and Associates Inc., MicroPort Scientific Corporation, Bard Peripheral Vascular Inc., Avinger Inc.

Get The Full Peripheral Artery Disease Market Report:

https://www.thebusinessresearchcompany.com/report/peripheral-artery-disease-global-market-report

Which Region Is The Leading Market For The Peripheral Artery Disease Market?

North America was the largest region in the peripheral artery disease market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the peripheral artery disease market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Peripheral Artery Disease Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/peripheral-artery-disease-global-market-report

Browse Through More Reports Similar to the Global Peripheral Artery Disease Market 2026, By The Business Research Company

Peripheral Artery Disease Market Report 2026

https://www.thebusinessresearchcompany.com/report/peripheral-artery-disease-global-market-report

Peripheral Vascular Devices And Equipment Market Report

https://www.thebusinessresearchcompany.com/report/peripheral-vascular-devices-and-equipment-global-market-report

Peripheral Neuropathy Market Report

https://www.thebusinessresearchcompany.com/report/peripheral-neuropathy-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795